Breaking News, Promotions & Moves

Parexel Names Chief Medical Officer

Dr. Charlotte Moser brings a combination of strategic clinical development leadership as well as experience as a principal investigator.

Author Image

By: Charlie Sternberg

Associate Editor

Charlotte Moser, MD, PhD, MBA.

Parexel, a clinical research organization (CRO) providing the full range of Phase I to IV clinical development services, has appointed Charlotte Moser, MD, PhD, MBA as Chief Medical Officer. As Chief Medical Officer, Moser will provide medical and scientific leadership globally, building on the company’s regulatory and therapeutic expertise with a significant focus on innovative drug development strategies and clinical trial design. “We’re thrilled to welcome Dr. Moser to Parexel,&#8...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics